Intestinal Diseases D007410

Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Intestinal Diseases

Description

Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.   MeSH

Subtype Terms (25)

Cecal Diseases
 

Colonic Diseases
40 drugs (25 approved, 15 experimental)

Duodenal Diseases
1 experimental drug

Dysentery
11 drugs (7 approved, 4 experimental)

Enteritis
15 drugs (4 approved, 11 experimental)

Enterocolitis
9 drugs (5 approved, 4 experimental)

HIV Enteropathy
1 approved drug

Ileal Diseases
 

Inflammatory Bowel Diseases
171 drugs (89 approved, 82 experimental)

Intestinal Atresia
3 drugs (2 approved, 1 experimental)

Intestinal Diseases, Parasitic
2 approved drugs

Intestinal Failure
6 drugs (1 approved, 5 experimental)

Intestinal Fistula
6 drugs (2 approved, 4 experimental)

Intestinal Neoplasms
467 drugs (233 approved, 234 experimental)

Intestinal Obstruction
14 drugs (12 approved, 2 experimental)

Intestinal Perforation
5 approved drugs

Intestinal Polyposis
7 approved drugs

Jejunal Diseases
 

Malabsorption Syndromes
28 drugs (12 approved, 16 experimental)

Mesenteric Ischemia
1 approved drug

Mesenteric Vascular Occlusion
 

Pneumatosis Cystoides Intestinalis
2 experimental drugs

Protein-Losing Enteropathies
5 drugs (3 approved, 2 experimental)

Rectal Diseases
9 drugs (6 approved, 3 experimental)

Zollinger-Ellison Syndrome
15 drugs (12 approved, 3 experimental)



Organization Involved with Phase 3 Indications (58)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.